Pimecrolimus enhances TLR2/6-induced expression of antimicrobial peptides in keratinocytes

62Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Calcineurin inhibitors are potent inhibitors of T-cell-receptor mediated activation of the adaptive immune system. The effects of this class of drug on the innate immune response system are not known. Keratinocytes are essential to innate immunity in skin and rely on toll-like receptors (TLRs) and antimicrobial peptides to appropriately recognize and respond to injury or microbes. In this study we examined the response of cultured human keratinocytes to pimecrolimus. We observed that pimecrolimus enhances distinct expression of cathelicidin, CD14, and human β-defensin-2 and β-defensin-3 in response to TLR2/6 ligands. Some of these responses were further enhanced by 1,25 vitamin D3. Pimecrolimus also increased the functional capacity of keratinocytes to inhibit growth of Staphylococcus aureus and decreased TLR2/6-induced expression of IL-10 and IL-1β. Furthermore, pimecrolimus inhibited nuclear translocation of NFAT and NF-κB in keratinocytes. These observations uncover a previously unreported function for pimecrolimus in cutaneous innate host defense. © 2008 The Society for Investigative Dermatology.

Cite

CITATION STYLE

APA

Büchau, A. S., Schauber, J., Hultsch, T., Stuetz, A., & Gallo, R. L. (2008). Pimecrolimus enhances TLR2/6-induced expression of antimicrobial peptides in keratinocytes. Journal of Investigative Dermatology, 128(11), 2646–2654. https://doi.org/10.1038/jid.2008.135

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free